A decade-long diabetes education initiative in Slovakia demonstrates a 57% lower risk of death among participants, highlighting the vital role of structured patient teaching in chronic disease management.
A structured diabetes education programme in Slovakia has been linked with sharply lower death rates among people with type 2 diabetes, adding fresh weight to the case for patient teaching as a core part of chronic disease care. According to a retrospective cohort study published in Diabetes Therapy, people who completed the education component of Dôvera Health Insurance Company’s diabetes management scheme had a 57% lower risk of death in the first two years after enrolment and a 32% lower risk thereafter than comparable patients who did not take part.
The findings come from an unusual real-world setting. Dôvera has run its programme for adults with type 2 diabetes since October 1, 2015, and says more than 6,000 people have taken part over its first decade. The insurer describes the scheme as a mix of structured education, lifestyle support and ongoing counselling, with sessions covering diet, physical activity, medication adherence, complication prevention and goal-setting. National Diabetes Programme material in Slovakia says the broader aim is to improve quality of life, reduce complications and support patients in following treatment and lifestyle advice.
The study itself, by Selvek, Saal, Mužik and Tkáč, used administrative health records from 2013 to 2024 and compared three groups: patients who completed the education programme, patients treated by diabetologists enrolled in the scheme but who themselves did not attend, and patients whose doctors were outside the programme. The researchers used propensity score matching to balance the groups and then tested the results with inverse probability weighting, a second statistical approach designed to mimic the effect of a population-wide rollout. In both analyses, the education component stood out as the element associated with better survival.
That distinction matters because the programme was not simply a financial or organisational intervention. Dôvera has also developed digital tools to help specialists and educators coordinate diabetes care, and other insurer-led materials describe the scheme as part of a wider effort to motivate patients and connect them with support. But in the Slovak study, the system-level machinery alone did not appear to deliver the mortality benefit. The survival signal emerged only when patients actually took part in the teaching sessions.
The result also fits a broader body of evidence suggesting that structured diabetes self-management education can improve long-term outcomes. The authors note that similar programmes in Austria and Hong Kong have been associated with lower mortality, while trial data and earlier reviews have found better glucose control and improved care processes among people who receive education. Dôvera has separately said its programme has been linked to improved blood sugar control, fewer hospital admissions and a 40% lower risk of death, underlining how insurers are increasingly using prevention and education as part of diabetes management. Even so, the Slovak researchers caution that their study was observational, meaning it cannot fully rule out the possibility that people who chose to attend were already more health-conscious or better able to manage their condition. Still, the size of the cohort, the long follow-up and the consistency of the findings across methods make the case for structured education difficult to ignore.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
